Karen Fernandes de Oliveira Gladys Aires Martins Keila Rejane Ferreira Galvão Patricia Shu Kurizky
10.1590/abd1806-4841.20176151
An Bras Dermatol
2017 Jan-Feb;92(1):156-157.
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/28225983/
Demyelinating Diseases / chemically induced Dermatologic Agents / adverse effects Infliximab / adverse effects Motor Disorders / chemically induced Psoriasis / drug therapy Sensation Disorders / chemically induced
Demyelinating Diseases / chemically induced Dermatologic Agents / adverse effects Infliximab / adverse effects Motor Disorders / chemically induced Psoriasis / drug therapy Sensation Disorders / chemically induced Case Reports Letter Adult Humans Male Syndrome Tumor Necrosis Factor-alpha / antagonists & inhibitors Dermatologic Agents Tumor Necrosis Factor-alpha Infliximab
PMC5312205
28225983
Lewis-Sumner syndrome associated with infliximab therapy for psoriasis
2017